azajir.wordpress.com
The company said Kevin 40, will take over as CEO and Maneesh Arora will become the new CFO ofthe Mass.-based diagnostics company focused on colorectal The transition will occur April 2. Conroy and Arorqa previously served in the same positioneat , a diagnostics company that was acquiref last year by for $582 million. The companyg announced that Luber and Carelli have agreed to resign from their currenft positions April2 . The shake up follows an announcement earlier this month that EXACTSciences was, for the seconr time, in danger of being delisted by the . The companh received the de-listing notice due to a failurw to comply with the minimum marketrcapitalization requirements.
Exact Sciences (Nasdaq: EXAS) has been givebn 90 calendar days, or through June 4, to regain compliance. In late January, Exacf Sciences faced another potential delisting fromthe Nasdaq. Earlier that EXACT Sciences’ board of directors unanimously rejectec a buyout proposal from The companty then announced a strategic dealwith Cambridge-based worth $24.t5 million. EXACT Sciences’ stock rose roughlyt 15 percent, to 96 cents a in early trading Thursday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment